Vulnerability · Published Aug 3, 2023 · Assigned by mitre

CVE-2023-33364

High 8.8

In plain English

A high-severity security flaw in the affected software. There are no confirmed reports of exploitation so far. The chance it is exploited in the next 30 days is estimated at 1.6% (higher than 75% of all known vulnerabilities).

Severity (CVSS NVD)8.8High
Exploit odds (30 days)1.6%top 24.6% of all CVEs
Exploited in the wildNo reportsCISA SSVC: none
Attack toolingNoneno public tooling known

Official description

An OS Command injection vulnerability exists in Suprema BioStar 2 before V2.9.1, which allows authenticated users to execute arbitrary OS commands on the BioStar 2 server.

Affected products (as reported)

VendorProductVersions
n/a n/a n/a

References